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Fluorescence in situ hybridization (FISH) is a cytogenetic tech-
nique used to detect the presence or absence and location of 
specific gene sequences. It can visualize specific cytogenetic 
abnormalities (copy number aberrations) such as chromosom-
al deletion, amplification, and translocation. FISH has been 
used in prenatal diagnosis and has served both as a diagnostic 
and as a prognostic marker for various sarcomas. More recent-
ly, FISH entered the field of dermatology in aiding the evalua-
tion of ambiguous melanocytic lesions. This article will discuss 
the concept of FISH, its application, and its advantages and 
limitations in dermatology, with an emphasis on melanoma.
hOW is Fish perFOrmed?
FISH involves the binding, or annealing, of fluorescence-
labeled, target-specific nucleic acid probes to their 
complementary DNA or RNA sequences and the subsequent 
visualization of these probes within cells in the tissue of 
interest. The tissue of interest can either be formalin-fixed, 
paraffin-embedded sections or fresh-frozen tissue.
First, the DNA or RNA sequences from the tissue of interest 
are allowed to denature to become single stranded. Next, a 
FISH probe is selected and applied. The selection of an appro-
priate FISH probe is a critical step for enhancing its value as a 
diagnostic test because FISH only detects those chromosomal 
abnormalities that are specifically targeted by the probes used. 
Different probes are used depending on the diseases or malig-
nancies under investigation. For example, a large number of 
recurrent cytogenetic abnormalities have been found in mela-
nomas by comparative genomic hybridization (CGH); these 
recurrent abnormalities serve as excellent candidates for FISH 
probes (Song et al., 2011).
Once the probe is selected, the fluorescence labeling of 
the probe can be done either directly or indirectly. In direct 
fluorescence labeling, the fluorochrome(s) to be detected by 
the fluorescence microscope is directly bound to the probe 
DNA. In indirect labeling, a hapten, which is not visible under 
a fluorescence microscope, is incorporated into the probe 
DNA. The hapten is then detected immunohistochemically 
by a fluorophore-tagged antibody directed against the hap-
ten. Next, the fluorescent-labeled probe and the target DNA 
or RNA sequences are brought together in the hybridization 
process, during which the fluorescent-labeled probe anneals 
to the targeted sequences. Posthybridization washings remove 
excessive unbound probe. The slides are then examined. 
Principles of FISH are illustrated in Figure 1.
Because FISH can be performed on formalin-fixed, paraf-
fin-embedded tissue, it is possible for a pathologist to select a 
specific area or areas of tumors to be examined by FISH. This 
enables correlation between FISH results and tumor morphol-
ogy under conventional light microscopy. For more details 
about FISH, readers are referred to the Fluorescence In Situ 
Hybridization (FISH)—Application Guide (Liehr, 2009).
inTerpreTaTiOn OF Fish
Each fluorescently labeled probe that hybridizes to a cell 
nucleus in the tissue of interest appears as a distinct fluores-
cent dot. Each dot identifies a single copy of the chromosomal 
locus with a homologous DNA sequence. Diploid nuclei will 
have two dots. If there is duplication in the region of interest, 
WHAT FISH DOES
•  FISH is used to visualize specific cytogenetic 
abnormalities.
•  It can serve as a supplementary diagnostic tool in 
pigmented lesions. However, it should not be used 
as a stand-alone test.
•  FISH cannot replace traditional histopathologic 
analysis.
•  FISH must correlate clinical, pathologic, and 
molecular information.
LIMITATIONS 
•  Probe design requires knowledge of specific 
chromosomal abnormalities to be studied.
• Cutoff signals may differ among laboratories.
•  Processing errors, imperfect hybridization, 
nonspecific binding, photobleaching, interobserver 
variability, and false-positive and -negative results 
are possible.
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CGH typically requires paraffin block preparation. In addition, 
copy number changes must be present in at least 30–50% of 
the cells for them to be evident on CGH analysis, whereas 
FISH requires only 20–30 well-visualized cells to provide an 
accurate count of fluorescence signals. As a result, FISH can 
be used both in large bulky tumors and in tumors in which 
the malignant component only contributes to a small propor-
tion of the overall cellular populations. Last, FISH probes can 
demonstrate balanced translocations that are not detectable at 
CGH resolution (Gerami and Zembowicz, 2011).
FishinG in dermaTOlOGY: melanOma and mOre
In contrast to melanoma and a subset of Spitz nevi, melano-
cytic nevi do not show chromosomal aberrations after karyo-
typing or CGH. These cytogenetic differences have been 
exploited to aid in the diagnosis of ambiguous melanocytic 
lesions. A landmark study to identify the most accurate FISH 
probes for melanoma was carried out in 2009 (Gerami et 
al., 2009a). Fourteen candidate cytogenetic abnormalities 
detected on CGH in prior studies were tested through FISH on 
148 melanomas and 153 nevi (including 17 Spitz nevi and 30 
the gain will result in more than two dots. Conversely, if there 
is a loss in the region of interest, one or no dots will result. In 
practice, several probes can be combined into a single multi-
color FISH experiment. For example, different probes can be 
labeled with different colors such as red, green, yellow, and 
aqua, which allows simultaneous interrogation of multiple 
cytogenetic signatures. Overlapping wavelength spectrums 
of the currently available fluorochromes limit the maximum 
number of probes in a single experiment to four (Gerami and 
Zembowicz, 2011). The number of dots per nucleus with a 
specific fluorescent color can be detected either manually or 
with software designed for automated analysis. Because of the 
intrinsic variability of FISH signals, a sufficient number of cells 
must be examined to yield a meaningful result.
FISH results are usually reported as a percentage of nuclei 
containing more than two copies of a particular locus of inter-
est or as a percentage of cells showing a loss or gain of a par-
ticular chromosomal region. The cutoff signals, or the exact 
percentage of cells needed to be considered an abnormal 
FISH result, must be determined and validated with appro-
priate controls for each probe. Because the cutoff values are 
empirically derived, the values may differ among laboratories. 
Needless to say, having rigorously interrogated cutoff values 
is important to the robustness of a FISH assay (Gerami and 
Zembowicz, 2011).
WhaT Fish cannOT dO: cOmparisOn BeTWeen  
Fish and cGh
To perform FISH, one must know what one is “FISHing” for. 
The FISH result is only positive or negative in relation to the 
interrogated chromosomal region. This is in contrast to CGH, 
in which copy number aberrations of the entire genome in 
a tissue of interest are interrogated in a single experiment. 
Compared with FISH, CGH is more expensive and has a 
longer turnaround time. Because cells must be microdissected, 
Figure 1. schematic diagram of the fluorescence in situ hybridization 
(Fish) technique. Reprinted from O’Connor, 2008.
Figure 2. histology and dual-target fluorescence in situ hybridization 
(Fish) with probe rmc11B022 for chromosome 11p and rmc11p008 
for chromosome 11q. (a) Case 2, normal CGH measurement; (b) case 13, 
gain of chromosome 11p; and (c) case 15, normal CGH measurement. FISH 
shows that infrequent cells with large nuclei (arrow) are polyploid; green 
signals, chromosome 11p; red signals, chromosome 11q. Reprinted with 
permission from Bastian et al., 1999.
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dysplastic nevi). A set of four probes targeting 6p25 (RREB1), 
6q23 (MYB), 11q13 (CCND1), and centromere 6 (CEP6) were 
determined to offer the best sensitivity and specificity, 86.7 and 
95.4%, respectively. The optimal discriminatory algorithms for 
defining positive FISH results based on these four probes were 
also established (Gerami et al., 2009a). These four probes are 
now commercially available and have been tested in a num-
ber of subsequent studies to aid in the diagnosis of ambiguous 
melanocytic lesions. FISH has been used to distinguish nevoid 
melanoma from mitotically active nevi (Gerami et al., 2009b).
The majority of Spitz nevi have a normal chromosomal 
analysis; however, a subset of Spitz nevi have been found 
to have increased copy number of chromosome 11p (Figure 
2) (Bastian et al., 1999). The increase in 11p has not been 
found in melanoma, allowing for possible differentiation in 
difficult-to-diagnose spitzoid melanocytic neoplasms.
FISH may play a future role in determining prognosis 
and identifying tumors with greater metastatic potential, 
although the clinical utility of these have yet to be deter-
mined. For example, FISH analysis for monosomy 3 has 
helped confirm the diagnosis of metastatic uveal melanoma 
(Busam et al., 2012).
Although FISH can serve as an adjunct in diagnosis of 
melanocytic lesions, there are intrinsic limitations to its 
results such as processing errors, imperfect hybridization, 
nonspecific binding, photobleaching caused by prolonged 
light exposure, and interobserver variability, as well as false-
negative and false-positive (tetraploidy) results. Furthermore, 
because melanomas are genetically heterogeneous, different 
genetic aberrations may be seen in different sections of the 
same tumor, underscoring the importance of selecting the 
most appropriate area(s) for FISH analysis.
Use of the FISH technique in other areas of clinical der-
matology has not been as well established. For example, 
although FISH is not routinely used in the diagnosis of 
cutaneous lymphomas, recent publications investigat-
ing specific gene rearrangement, deletion, or translocation 
have shown the potential for future applications in cutane-
ous T-cell lymphoma to provide a biologic basis for possi-
ble gene-directed therapy as well as prognosis (Marty et al., 
2008; Pham-Ledard et al., 2010). Figures 3 and 4 show the 
use of FISH to identify IFN regulatory factor 4 gene (IRF4) 
translocation in certain cases of cutaneous T-cell lympho-
ma. Figure 3 shows in schematic fashion how break-apart, 
dual-color fluorophore-labeled probes can be used to dem-
onstrate translocations, as well as extra copies of the locus 
of interest. IRF4 gene probes directed against the 5′ and 3′ 
ends were differentially labeled (one red, one green) and 
hybridized. Figure 4 shows a comparison of binding to nor-
mal and diseased tissues; the FISH pattern in Figure 4d is 
normal, with dual color (red and green). In Figure 4h, the 
signal pattern is split (one locus is dual color, but the other 
red and green are split), which is consistent with a transloca-
tion. Figure 4l demonstrates an extra signal, which is con-
sistent with an extra copy of the IRF4 locus. More recently, 
FISH has been utilized to assess clonality in bone marrow 
and skin infiltrates in patients with neutrophilic dermatoses 
and myeloid malignancy (Sujobert et al., 2012).
Figure 4. histological, immunophenotypical, and fluorescence in situ 
hybridization (Fish) aspects of three typical cases with and without IRF4 locus 
rearrangement. Left: Lymph node section of cutaneous anaplastic large-cell 
lymphoma (C-ALCL) without IRF4 locus rearrangement. (a) Hematoxylin–eosin 
and safran (HES). Bar = 20 μm. (b) Positivity of CD30 immunostaining.  
(c) Immunostaining shows expression of multiple myeloma antigen 1 (MUM1) 
by more than 85% of tumor cells. (d) Normal FISH signal pattern (2F). Bar = 
5 μm. Middle: Skin section of case 6 with C-ALCL and IRF4 rearrangement.  
(e) HES, ×400. (f) Positivity of CD30 immunostaining. (g) Immunostaining 
shows MUM1 expression by more than 85% of tumor cells. (h) Split FISH signal 
pattern (1F–1R–1G). Bar = 5 μm. Right: Skin section of case 8 with transformed 
mycosis fungoides and IRF4 locus rearrangement. (i) HES, ×400. (j) Positivity 
of CD30 immunostaining. (k) Immunostaining shows MUM1 expression by 
10–50% of large tumor cells. (l) FISH signal pattern shows an extra signal of 
SpectrumGreen-labeled RP11-164H16 (2F+1G extra signal), indicating that the 
break point maps to the 6p25 region in the genomic area corresponding to the 
RP11-164H16 sequence. Bar = 5 μm. Reprinted with permission from Pham-
Ledard et al., 2010.
Figure 3. IRF4 locus-specific fluorescence in situ hybridization (Fish) 
strategy. (a) Schematic representation of all BAC clones hybridizing to the 6p25 
region used in this study. RP11-119L15, CTD-2317K17, and CTD-3052J12 
BAC clones, which showed nonspecific hybridization on chromosome 16, 
were discarded. The break-apart BAC probe strategy used CTD-2308G5 as the 
5′ IRF4 BAC probe and RP11-164H16 as the 3′ IRF4 BAC probe. (b) The FISH 
signal pattern expected in interphase nuclei samples. Normal nuclei would 
exhibit a two-fusion (2F) signal pattern corresponding to the juxtaposition 
of BAC clones probes. Nuclei with an IRF4 locus break point, suggesting 
translocation, would show a split signal pattern (1F–1R–1G). Nuclei with extra 
copies of a nonrearranged IRF4 locus should exhibit more than a 2F signal 
pattern. Reprinted with permission from Pham-Ledard et al., 2010.
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summarY
FISH is a powerful technique used to visualize specific cyto-
genetic abnormalities. Its most significant role in dermatology 
to date lies in its ability to aid in the diagnosis and manage-
ment of ambiguous melanocytic lesions. Although recent stud-
ies have suggested that FISH can be used as a supplementary 
diagnostic tool in pigmented lesions, FISH must not be used as 
a stand-alone test, and it cannot replace traditional histopath-
ologic analysis. One must correlate clinical, pathologic, and 
molecular information. “FISHing” in dermatology continues to 
evolve, and we look forward to future studies to further delin-
eate its roles in various dermatologic diseases.
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SUPPLEMENTARY MATERIAL
Answers and a PowerPoint slide presentation appropriate for journal club or 
other teaching exercises are available at http://dx.doi.org/10.1038/jid.2013.120.
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QUESTIONS
1. What does Fish detect?
A. Protein structure abnormalities.
B.  Specific chromosome copy-number aberrations.
C.  Presence of specific antigens.
D. Presence of complement.
2.  Where does the Fish probe localize to?
A. Golgi apparatus.
B. Cytoplasm.
C. Cell membrane.
D. Nucleus.
3. What is the Fish probe composed of?
A. Proteins.
B. Lipids.
C. Carbohydrates.
D. Nucleic acids.
4.  What is the maximum number of Fish probes that 
can be used in a single experiment?
A. Two.
B. Three.
C. Four.
D. Five.
Answers to the questions and an opportunity to comment on the 
article are available on our blog: http://blogs.nature.com/jid_jottings/.
